Search filters

List of works by Shigeki Yagyu

3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus

scientific article published on 20 January 2016

A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines ⬇️

scientific article published on December 23, 2012

An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells

scientific article

Autologous non-human primate model for safety assessment of <i>piggyBac</i> transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor

scientific article published on 22 November 2020

Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity

scientific article

Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastoma ⬇️

scientific article published on January 16, 2011

Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.

scientific article published on 18 June 2015

Multiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switch

scientific article

Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee

scientific article published on 24 July 2019

Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression ⬇️

scientific article published on August 17, 2011

The novel histone deacetylase inhibitor OBP-801 induces apoptosis in rhabdoid tumors by releasing the silencing of NOXA

scientific article published on 26 August 2020

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

scientific article published on 4 May 2015

Paulina is supported by:

About Paulina

Help